Solubility survey of fragments of the neurofibromatosis type 1 protein neurofibromin

被引:22
作者
Bonneau, Fabien [1 ]
Lenherr, Esther D. [1 ]
Pena, Vladimir [1 ]
Hart, Darren J. [2 ]
Scheffzek, Klaus [1 ]
机构
[1] European Mol Biol Lab, Struct & Computat Biol & Dev Biol Units, D-69117 Heidelberg, Germany
[2] European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble 9, France
关键词
Disease protein; Ras; Signal transduction; G protein regulator; Cancer; Tumor suppressor; NF1; TUMOR-SUPPRESSOR; GAP-RELATED DOMAIN; GENE-PRODUCT; STRUCTURAL BASIS; RAS ONCOGENES; BINDING; GTPASE; PHOSPHORYLATION; IDENTIFICATION; INTERACTS;
D O I
10.1016/j.pep.2008.12.001
中图分类号
Q5 [生物化学];
学科分类号
070307 [化学生物学];
摘要
The protein giant neurofibromin (320 kDa) is the protein product of the NF1 tumor suppressor gene, alterations of which are responsible for the pathogenesis of neurofibromatosis type 1 (NF1). Neurofibromin is a Ras-specific GTPase activating protein (RasGAP) that, 15 years after the cloning of the gene, remains the only clearly defined function of the protein. In a structural proteomics approach, we aimed at defining functions beyond RasGAP activity based on the discovery of structural modules. Given the poor outcome of domain prediction tools, we have undertaken a fragment solubility survey covering the full protein sequence, with the aim of defining new domain boundaries or fragments that could be investigated by biochemical methods including structural analysis. More than 200 constructs have been expressed and tested for solubility in small scale assays. Boundaries were chosen based upon secondary structure predictions, sequence conservation among neurofibromin orthologues and chemical properties of amino acids. Using this strategy we recently discovered a novel bipartite module in neurofibromin. We have expanded our study to include ESPRIT, a library-based construct screen, to perform fragment testing at a finer level with respect to the choice of terminal residues. Our study confirms earlier notions about the challenges neurofibromin presents to the biochemist and points to strategies whereby the success rate may be enhanced in the future. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:30 / 37
页数:8
相关论文
共 38 条
[1]
GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN (GAP) INTERACTS WITH THE P21-RAS EFFECTOR BINDING DOMAIN [J].
ADARI, H ;
LOWY, DR ;
WILLUMSEN, BM ;
DER, CJ ;
MCCORMICK, F .
SCIENCE, 1988, 240 (4851) :518-520
[2]
Structural differences in the minimal catalytic domains of the GTPase-activating proteins p120(GAP) and neurofibromin [J].
Ahmadian, MR ;
Wiesmuller, L ;
Lautwein, A ;
Bischoff, FR ;
Wittinghofer, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (27) :16409-16415
[3]
Confirmation of the arginine-finger hypothesis for the GAP-stimulated GTP-hydrolysis reaction of Ras [J].
Ahmadian, MR ;
Stege, P ;
Scheffzek, K ;
Wittinghofer, A .
NATURE STRUCTURAL BIOLOGY, 1997, 4 (09) :686-689
[4]
HEAT REPEATS IN THE HUNTINGTONS-DISEASE PROTEIN [J].
ANDRADE, MA ;
BORK, P .
NATURE GENETICS, 1995, 11 (02) :115-116
[5]
Protein sequence databases [J].
Apweiler, R ;
Bairoch, A ;
Wu, CH .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2004, 8 (01) :76-80
[6]
Sec14p-like domains in NF1 and Dbl-like proteins indicate lipid regulation of Ras and Rho signaling [J].
Aravind, L ;
Neuwald, AF ;
Ponting, CP .
CURRENT BIOLOGY, 1999, 9 (06) :R195-R197
[7]
THE NF1 LOCUS ENCODES A PROTEIN FUNCTIONALLY RELATED TO MAMMALIAN GAP AND YEAST IRA PROTEINS [J].
BALLESTER, R ;
MARCHUK, D ;
BOGUSKI, M ;
SAULINO, A ;
LETCHER, R ;
WIGLER, M ;
COLLINS, F .
CELL, 1990, 63 (04) :851-859
[8]
RAS GENES [J].
BARBACID, M .
ANNUAL REVIEW OF BIOCHEMISTRY, 1987, 56 :779-827
[9]
CHARACTERIZATION OF FULL-LENGTH NEUROFIBROMIN - TUBULIN INHIBITS RAS GAP ACTIVITY [J].
BOLLAG, G ;
MCCORMICK, F ;
CLARK, R .
EMBO JOURNAL, 1993, 12 (05) :1923-1927
[10]
DIFFERENTIAL REGULATION OF RASGAP AND NEUROFIBROMATOSIS GENE-PRODUCT ACTIVITIES [J].
BOLLAG, G ;
MCCORMICK, F .
NATURE, 1991, 351 (6327) :576-579